Stammdaten
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies in Puerto Rico, the United States, Europe, and Brazil. Its technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.
Unternehmen & Branche
| Name | Pharma-Bio Serv, Inc. |
|---|---|
| Ticker | PBSV |
| CIK | 0001304161 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Healthcare Information Services |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 11,5 Mio. USD |
| Beta | 0,73 |
| Dividendenrendite | 0,08 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-01-31 | 10-Q | 2,294,966 | 32,860 | 0.00 | 13,548,426 | 10,238,731 |
| 2025-10-31 | 10-K | 9,001,096 | -100,463 | 0.00 | 13,653,046 | 11,914,247 |
| 2025-07-31 | 10-Q | 1,963,083 | -204,250 | 0.01 | 13,585,578 | 11,926,684 |
| 2025-04-30 | 10-Q | 2,417,044 | 95,353 | 0.00 | 13,903,541 | 12,123,308 |
| 2025-01-31 | 10-Q | 2,471,333 | 8,536 | 0.00 | 16,077,494 | 11,996,129 |
| 2024-10-31 | 10-K | 9,509,279 | -777,619 | -0.03 | 16,292,230 | 13,715,327 |
| 2024-07-31 | 10-Q | 2,418,163 | -309,194 | 0.01 | 16,318,509 | 13,686,968 |
| 2024-04-30 | 10-Q | 2,377,617 | -213,817 | -0.01 | 16,924,653 | 13,953,373 |
| 2024-01-31 | 10-Q | 2,380,187 | -270,719 | -0.01 | 19,231,246 | 14,156,377 |
| 2023-10-31 | 10-K | 16,976,856 | 1,310,180 | 0.06 | 19,902,061 | 16,126,785 |
| 2023-07-31 | 10-Q | 4,577,167 | 526,242 | 20,296,599 | 16,185,481 | |
| 2023-04-30 | 10-Q | 4,563,142 | 404,654 | 19,618,285 | 15,674,132 | |
| 2023-01-31 | 10-Q | 4,238,356 | 426,432 | 20,900,410 | 16,990,338 | |
| 2022-10-31 | 10-K | 19,398,727 | 1,006,684 | 20,650,846 | 16,557,570 | |
| 2022-07-31 | 10-Q | 4,774,103 | 288,034 | 20,328,845 | 16,148,592 | |
| 2022-04-30 | 10-Q | 4,967,318 | 240,027 | 20,161,196 | 15,894,690 | |
| 2022-01-31 | 10-Q | 5,019,104 | 305,244 | 22,074,290 | 17,430,732 | |
| 2021-10-31 | 10-K | 20,115,175 | -2,089,240 | 23,921,201 | 18,914,131 | |
| 2021-07-31 | 10-Q | 4,987,909 | 2,275,118 | 28,594,632 | 23,840,731 | |
| 2021-04-30 | 10-Q | 5,041,666 | 240,271 | 27,898,943 | 21,548,951 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.